Cafepharma Today

April 18 2024 - AI identifies new potential treatments for Parkinson’s Disease
AI identifies new potential treatments for Parkinson’s Disease
FDA fast-tracks AskBio’s heart failure gene therapy
Biopharma M&A more than doubled in the first quarter compared to the year prior
Vertex inches closer to acute pain market with FDA application acceptance
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

For Chinese biotechs, the out-licensing business is scorching hot. Could geopolitics rain on their parade?
Fierce Biotech
Thursday, April 11, 2024 - 11:09am
tags:
China, biotech, out-licensing, geopolitics
Top five biopharma companies hiring in San Diego
BioSpace
Thursday, April 11, 2024 - 10:55am
tags:
San Diego, biotech, hirings, Avidity Biosciences, Element Biosciences, AnaptysBio, Fate Therapeutics, Takeda
FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test
Pharmaphorum
Thursday, April 11, 2024 - 10:52am
tags:
diagnostics, Roche, Eli Lilly, Alzheimer's disease, FDA, breakthrough designation
Reports: Applying gen AI to marketing can help life-sci firms unlock billions
Medical Marketing and Media
Thursday, April 11, 2024 - 10:46am
tags:
pharma marketing, artificial intelligence, generative AI
Vertex to buy kidney disease drugmaker Alpine for $4.9B
BioPharma Dive
Wednesday, April 10, 2024 - 6:05pm
tags:
Vertex Pharmaceuticals, M&A, Alpine Immune Sciences, IgA nephropathy
J&J, Rallybio partner on drug development for rare fetal condition
BioPharma Dive
Wednesday, April 10, 2024 - 6:01pm
tags:
JNJ, Rallybio, FNAIT, drug development
Alkermes reports data from Phase Ib narcolepsy treatment trial
Clinical Trials Arena
Wednesday, April 10, 2024 - 6:00pm
tags:
Alkermes, clinical trials, narcolepsy, ALKS 2680
Leading AstraZeneca investor defends CEO pay ahead of shareholder vote
Fierce Pharma
Wednesday, April 10, 2024 - 5:47pm
tags:
AstraZeneca, Pascal Soriot, Pharma CEOs, executive compensation
AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit
BioSpace
Wednesday, April 10, 2024 - 5:44pm
tags:
AACR, oncology, FDA, accelerated approvals
Novartis pauses enrollment in some Kisqali trials to fix manufacturing
BioPharma Dive
Wednesday, April 10, 2024 - 5:28pm
tags:
Novartis, Kisqali, drug manufacturing, breast cancer, clinical trials
The IRA Is Already Curtailing Small Molecule Drug Development. Here’s How to Reverse That.
BioSpace
Wednesday, April 10, 2024 - 11:27am
tags:
small molecule drugs, drug development, Inflation Reduction Act, innovation
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wednesday, April 10, 2024 - 11:24am
tags:
oncology, M&A, AbbVie, Immunogen, Bristol Myers Squibb, Mirati Therapeutics, RayzeBio, Novartis, MorphoSys, AstraZeneca, Fusion Pharmaceuticals, JNJ, Ambrx, Gracell
AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer
BioSpace
Wednesday, April 10, 2024 - 9:59am
tags:
Merck, Kelun-Biotech, SKB264, gastric cancer, antibody-drug conjugate, clinical trials, AACR
New Cardiovascular Company Emerges from Stealth Mode
Medical Devices and Diagnostics Industry
Wednesday, April 10, 2024 - 9:57am
tags:
Reprieve Cardiovascular, funding, acute decompensated heart failure
Bristol Myers-backed TORL secures $158M to march army of ADCs through clinic
Fierce Biotech
Wednesday, April 10, 2024 - 9:52am
tags:
Bristol Myers Squibb, TORL BioTherapeutics, antibody-drug conjugate, funding
Invenra, Astellas sign bispecific antibody discovery agreement
Pharmaceutical Business Review
Wednesday, April 10, 2024 - 9:50am
tags:
Astellas, Invenra, B-Body, bispecific antibodies, R&D
GLP-1s Like Novo Nordisk’s Ozempic Do Not Increase Thyroid Cancer Risk: Study
BioSpace
Wednesday, April 10, 2024 - 9:48am
tags:
Novo Nordisk, Ozempic, Victoza, GLP-1 agonist, thyroid cancer
Poor Customer Data Management Costs Pharma Companies Money: Report
BioSpace
Wednesday, April 10, 2024 - 9:27am
tags:
customer data, data management
SpineX eyes FDA submission as neurogenic bladder trial hits milestone
Clinical Trials Arena
Wednesday, April 10, 2024 - 9:23am
tags:
SpineX, neuromodulation, Medtech, clinical trials
Bayer, Google partner on AI for time-pressed radiologists
Pharmaphorum
Wednesday, April 10, 2024 - 9:21am
tags:
Bayer, Google, Google Cloud, artificial intelligence, R&D, radiologists

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels
Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)
Drug Channels

Latest Jobs

Pharmaceutical Sales- Associate Territory Manager- Primary Care
Washington DC, 20066
Eli Lilly and Company
Sales Representative
Nampa, ID, 83651
Bartlett Roofing
Pharmaceutical Sales Representative (PSR)
Iowa City, IA, 52246
Syneos Health, Inc
Diagnostics Hematology Specialist (Michigan)
Michigan, ND, 58259
Adaptive Biotechnologies
Professional Pharmaceutical Sales Representative
Pueblo, CO, 81001
Syneos Health, Inc
Pharmaceutical Sales- Associate Territory Manager- Primary Care
Covington, Georgia
Eli Lilly and Company
Manager, Inside Sales
Austin, TX
AbbVie
Vice President of Sales
Durham, NC
Confidential
Aesthetic Surgical Rep -Allergan Aesthetics, Richmond/Virginia Beach, VA
Richmond, VA, 23234
AbbVie, Inc
Generic Pharmaceuticals Inside Sales Representative
Cincinnati, OH, 45201
BluPax Pharma
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information